Sandoz

SANDOZ NEWSROOM (2 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2026 2025 2024 2023 2022 2019 2018 2017 2016 2015 2014 2013 2012

Novartis future growth prospects secured by industry-leading pipeline, with more than 139 projects with 73 new compounds

PRESS RELEASE -- 10, November 2012

Pharmaceuticals Division growth over the next 5 years expected to bedriven by portfolio of recently launched products Division had 7 blockbusters in portfolio in 2011 and expects to achieve 14 or more blockbusters by 2017 Industry-leading Pharmaceuticals pipeline with 73 … Read the full press release →

Sandoz begins phase III studies in the United States for biosimilar epoetin alfa

PRESS RELEASE -- 3, November 2012

Holzkirchen, Germany, 3-11-2012 — /europawire.eu/ — Sandoz, the global leader in biosimilars, has started patient enrolment in a late stage clinical trial in the United States for its biosimilar epoetin alfa. The Phase III study will compare safety and efficacy of … Read the full press release →